Coherus Oncology, Inc. (CHRS)

NASDAQ: CHRS · Real-Time Price · USD

1.410

-0.050 (-3.42%)

At close: Aug 28, 2026, 4:00 PM EDT

1.390

-0.020 (-1.42%)

After-hours: Aug 28, 2026, 7:49 PM EDT

Coherus Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	218	172	159	371	778	1,225
Market Cap Growth	64.41%	7.95%	-57.13%	-52.31%	-36.55%	-2.13%
Enterprise Value	167	34	361	718	971	1,176
Last Close Price	1.41	1.42	1.38	3.33	7.92	15.96

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	1.02	5.58	-	-	-
Forward PE	-	138.29	23.31	23.31	23.31	23.31
PS Ratio	4.28	4.07	6.03	1.44	3.68	3.75
PB Ratio	3.58	2.81	-1.20	-1.92	-5.66	12.54
P/TBV Ratio	13.75	11.62	-	-	-	13.02
PEG Ratio	-	62.23	62.23	62.23	62.23	62.23

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.27	0.81	13.67	2.79	4.60	3.60

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.89	0.89	-2.26	-2.49	-3.50	4.29
Net Debt / Equity Ratio	-0.84	-1.93	-1.31	-1.88	-2.10	0.02
Net Debt / EBITDA Ratio	0.34	0.68	-0.94	-1.92	-1.14	-0.01
Net Debt / FCF Ratio	0.28	0.85	-8.45	-2.08	-1.20	-0.05
Asset Turnover	0.16	0.12	0.05	0.46	0.36	0.43
Inventory Turnover	3.11	3.74	0.26	3.14	1.83	1.41
Quick Ratio	1.58	1.36	0.88	1.14	2.17	3.27
Current Ratio	1.77	1.47	1.21	1.43	2.75	3.64
Return on Equity (ROE)	-178.39%	-	-	-	-	-151.62%
Return on Assets (ROA)	-30.52%	-31.20%	-21.92%	-21.75%	-27.68%	-21.68%
Return on Invested Capital (ROIC)	-	-324.31%	-81.60%	-60.38%	-116.31%	-205.76%
Return on Capital Employed (ROCE)	-133.10%	-149.60%	-114.20%	-64.90%	-75.10%	-51.30%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-60.65%	97.89%	17.93%	-64.15%	-37.52%	-23.43%
FCF Yield	-85.40%	-80.70%	-12.86%	-47.16%	-31.01%	-3.16%
Buyback Yield / Dilution	-14.13%	-2.26%	-21.65%	-21.30%	-2.89%	9.63%

SEC Filings: 10-K · 10-Q